Atopic Dermatitis

Molecular changes in barrier function and inflammatory markers characterized the pathophysiology of atopic dermatitis at age 1 month, according to a study published in the Journal of the European Academy of Dermatology and Venereology.

An increased rate of venous thromboembolism is associated with atopic dermatitis in adults, although that increased risk is small, according to a study.

The quality and quantity of ultraviolet B phototherapy sessions for the treatment of atopic dermatitis did not increase the risk of skin cancer development in patients, according to a study.

Patients with moderate to severe atopic dermatitis that switched from dupilumab to upadacitinib experienced significant improvement in efficacy and itch as early as week 4 of treatment, according to a study.

Newborns of mothers with alopecia areata experienced a significantly greater risk for developing alopecia and accompanying comorbidities, according to a study.

Mindfulness and self-compassion training may be an effective treatment option to increase the quality of life for adults with atopic dermatitis, according to data published in JAMA Dermatology.

As demand for allergy and asthma care grows, physician assistants now have a greater role in providing that treatment. The Association of PAs in Allergy, Asthma & Immunology aims to support these professionals with its upcoming conference.

The information in YouTube videos about the nutritional treatment of atopic diseases tends to be poor and include misleading content, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

New data from a phase 2 study evaluating the short-term clinical benefits of Opzelura cream 1.5% showed a reduction in itch among adults with mild to moderate atopic dermatitis, Incyte announced in a press release.